Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | CES2 | O00748 | 2/20 | 0.53 |
| ▸ | CES1 | P23141 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | CTSD | P07339 | 1/20 | 0.43 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 4/20 | 0.39 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4613678 | 0.89 | LMNA (0.50) | LMNACES2CES1MAPK1KDM4E | |
| SCHEMBL7326944 | 0.86 | LMNA (0.53) | LMNACES2CES1MAPK1KDM4E | |
| SCHEMBL1395462 | 0.84 | LMNA (0.52) | LMNACES2CES1MAPK1KDM4E | |
| SCHEMBL2053138 | 0.84 | LMNA (0.52) | LMNACES2CES1MAPK1KDM4E | |
| SCHEMBL754132 | 0.81 | CYP2C19 (0.58) | LMNACES2CES1MAPK1ALDH1A1 | |
| SCHEMBL4769362 | 0.80 | LMNA (0.47) | LMNACES2CES1MAPK1KDM4E | |
| SCHEMBL11667579 | 0.80 | LMNA (0.47) | LMNACES2CES1MAPK1KDM4E | |
| Formic Acid SCHEMBL28872029 | 0.79 | LMNA (0.46) | LMNACES2CES1MAPK1KDM4E | |
| SCHEMBL5928515 | 0.79 | ALDH1A1 (0.62) | LMNACES2CES1KDM4EALDH1A1 | |
| SCHEMBL5843726 | 0.79 | MDM4 (0.53) | LMNACES2CES1MAPK1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104672332-B | Antibody, ELISA method and kit for detecting free gossypol | 武汉市畜牧兽医科学研究所 | 2018-10-09 | — | — | CN | disclosed |
| CN-104558176-B | Monoclonal antibody and enzyme-linked immunoassay method and kit for detecting androgens medicine | 华中农业大学 | 2017-09-01 | — | — | CN | disclosed |
| CN-104558171-B | Monoclonal antibody and enzyme-linked immunoassay method and kit for detecting methyltestosterone | 华中农业大学 | 2017-07-04 | — | — | CN | disclosed |
| CN-104672332-A | Antibody for testing free gossypol, ELISA (enzyme-linked immune sorbent assay) method and kit | WUHAN RES INST OF ANIMAL AND VETERINARY SCIENCE | 2015-06-03 | — | — | CN | disclosed |
| CN-104558176-A | Monoclonal antibody, enzyme-linked immunosorbent assay method and kit for detecting androgens | UNIV HUAZHONG AGRICULTURAL | 2015-04-29 | — | — | CN | disclosed |
| CN-104558171-A | Monoclonal antibody, enzyme linked immunosorbent assay and kit for detecting methyltestosterone | UNIV HUAZHONG AGRICULTURAL | 2015-04-29 | — | — | CN | disclosed |
| CN-102617589-A | Artificial antigen for aflatoxin M1 and antibody prepared by same | UNIV CHINA AGRICULTURAL | 2012-08-01 | — | — | CN | disclosed |
| CN-101105492-B | Monoclonal antibody and enzyme-linked immunoassay method and reagent kit for detecting tylosin and tilmicosin residue | UNIV HUAZHONG AGRICULTURAL | 2011-05-04 | — | — | CN | disclosed |
| CN-101105492-A | Monoclonal antibody and enzyme-linked immunoassay method and reagent kit for detecting tylosin and tilmicosin residue | UNIV HUAZHONG AGRICULTURAL (CN) | 2008-01-16 | — | — | CN | disclosed |
| US-20070258969-A1 | Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers | GALECTIN THERAPEUTICS, INC. | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258969-A1 | Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers | CD44, ALG1, FUT6 | LMNA 2062/4885CES2 2336/4885CES1 2251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.